Tricuspid valve Group B streptococcal endocarditis after an elective termination of pregnancy

Clinical Cardiology

Volumn 23, Issue 4, 2000, Pages 301-303

  Kangavari, Simon ^a   Collins, Jennifer ^a   Cercek, Bojan ^a   Atar, Shaul ^a   Siegel, Robert ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Abortion; Endocarditis; Group B streptococcus; Tricuspid valve

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CAPTOPRIL; CEFALEXIN; CEFUROXIME; ERYTHROMYCIN; GENTAMICIN;

ABORTION; ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; BLOOD CULTURE; CARDIOVASCULAR DISEASE; CASE REPORT; CURETTAGE; FEMALE; HUMAN; INFECTIOUS COMPLICATION; PREGNANCY TERMINATION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; THERAPEUTIC ABORTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRICUSPID VALVE DISEASE; UTERINE CERVIX DILATATION;

EID: 0034071029     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230418     Document Type: Article

References (10)

1. Seaworth BJ, Durack DT: Infective endocarditis in obstetric and gynecologic practice. Am J Obstet Gynecol 1986;154:180-188
2. Ward H: Bacterial endocarditis in pregnancy. Aust N Z J Obstet Gynaecol 1971;11:189-191
3. Pringle SD, McCartney AC, Marshall DAS, Cobbe S: Infective endocarditis caused by Streptococcus agalactiae. Int J Cardiol 1989;24:179-183
4. Schwartz B: Invasive group B streptococcal disease in adults. J Am Med Assoc 1991;266:1112-1114
5. Scully BE, Spriggs D, New HC: Streptococcus agalactiae (group B) endocarditis: A description of twelve cases and review of literature. Infection 1987;15(3):169-176
6. Atri ML, Cohen DH: Group B streptococcus endocarditis following second trimester abortion. Arch Intern Med 1990;149:2579-2580
7. Jemsek JG, Gentry LO, Greenberg SB: Malignant group B streptococcal endocarditis associated with saline-induced abortion. Chest 1979;76(6):695-696
8. Vartian CV, Septimus EJ: Tricuspid valve group B streptococcal endocarditis following elective abortion. Rev Infectious Dis 1991; 13:997-998
9. Parillo JE, Burch C, Shelhamer JH: A circulating myocardial depressant substance in humans with septic shock: Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985; 76:1539-1553
10. Parker MM, Shelhamer JH, Bacharach SL: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984;100:483-490